$LUMO
Lumos Pharma Inc Stock $lumo

$lumo Overview Financials Valuation SEC Filings Company Website

2012 Q1 Form 10-Q Financial Statement

#000112623412000024 Filed on May 10, 2012

Income Statement

Concept	2012 Q1	2011 Q1
Revenue	$471.0K	$604.0K
YoY Change	-22.02%	101.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.500M	$1.300M
YoY Change	15.38%	85.71%
% of Gross Profit
Research & Development	$3.830M	$3.180M
YoY Change	20.44%	9.66%
% of Gross Profit
Depreciation & Amortization	$175.0K	$174.0K
YoY Change	0.57%
% of Gross Profit
Operating Expenses	$5.288M	$4.496M
YoY Change	17.62%	24.89%
Operating Profit	-$4.817M	-$3.892M
YoY Change	23.77%
Interest Expense	$0.00	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$25.00K	-$6.000K
YoY Change	316.67%
Pretax Income	-$4.800M	-$3.900M
YoY Change	23.08%	18.18%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$4.842M	-$3.897M
YoY Change	24.25%	21.78%
Net Earnings / Revenue	-1028.03%	-645.2%
Basic Earnings Per Share	-$0.23	-$1.07
Diluted Earnings Per Share	-$2.087M	-$1.696M
COMMON SHARES
Basic Shares Outstanding	20.61M shares	3.636M shares
Diluted Shares Outstanding	20.61M shares	3.636M shares

Balance Sheet

Concept	2012 Q1	2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$35.80M
YoY Change
Cash & Equivalents	$33.27M	$6.416M
Short-Term Investments	$2.500M
Other Short-Term Assets	$300.0K
YoY Change
Inventory
Prepaid Expenses	$292.0K
Receivables
Other Receivables
Total Short-Term Assets	$37.22M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$6.229M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$6.229M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$37.22M
Total Long-Term Assets	$6.229M
Total Assets	$43.45M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$803.0K
YoY Change
Accrued Expenses	$1.226M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$93.00K
YoY Change
Total Short-Term Liabilities	$2.310M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$6.900M
YoY Change
Other Long-Term Liabilities	$1.500M
YoY Change
Total Long-Term Liabilities	$8.339M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.310M
Total Long-Term Liabilities	$8.339M
Total Liabilities	$10.65M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$207.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$32.80M
YoY Change
Total Liabilities & Shareholders Equity	$43.45M
YoY Change

Cashflow Statement

Concept	2012 Q1	2011 Q1
OPERATING ACTIVITIES
Net Income	-$4.842M	-$3.897M
YoY Change	24.25%	21.78%
Depreciation, Depletion And Amortization	$175.0K	$174.0K
YoY Change	0.57%
Cash From Operating Activities	-$5.640M	-$4.336M
YoY Change	30.07%
INVESTING ACTIVITIES
Capital Expenditures	$709.0K	$48.00K
YoY Change	1377.08%
Acquisitions	$0.00	$0.00
YoY Change
Other Investing Activities	$100.0K	$300.0K
YoY Change	-66.67%
Cash From Investing Activities	-$659.0K	$221.0K
YoY Change	-398.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$131.0K	$0.00
YoY Change
Debt Paid & Issued, Net	$23.00K	$23.00K
YoY Change	0.0%
Cash From Financing Activities	$78.00K	-$41.00K
YoY Change	-290.24%
NET CHANGE
Cash From Operating Activities	-$5.640M	-$4.336M
Cash From Investing Activities	-$659.0K	$221.0K
Cash From Financing Activities	$78.00K	-$41.00K
Net Change In Cash	-$6.221M	-$4.156M
YoY Change	49.69%
FREE CASH FLOW
Cash From Operating Activities	-$5.640M	-$4.336M
Capital Expenditures	$709.0K	$48.00K
Free Cash Flow	-$6.349M	-$4.384M
YoY Change	44.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	918000	USD
CY2011Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	196000	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1670000	USD
CY2012Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	803000	USD
CY2011Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1867000	USD
CY2012Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1226000	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2911000	USD
CY2012Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3017000	USD
CY2012Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	118909000	USD
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	118043000	USD
CY2012Q1	us-gaap	Assets Assets	43447000	USD
CY2011Q4	us-gaap	Assets Assets	48379000	USD
CY2012Q1	us-gaap	Assets Current AssetsCurrent	37218000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	42788000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1424000	USD
CY2012Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	173000	USD
CY2011Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2011Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	121000	USD
CY2012Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	123000	USD
CY2012Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	61000	USD
CY2011Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	94000	USD
CY2011Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6416000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33269000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39490000	USD
CY1999Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10572000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	33269000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6221000	USD
CY2011Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4156000	USD
CY2012Q1	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	2490000	USD
CY2011Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	2490000	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-8800000	USD
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	38833334	shares
CY2012Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	38833334	shares
CY2012Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20672029	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20591240	shares
CY2012Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20672029	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20591240	shares
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	206000	USD
CY2012Q1	us-gaap	Common Stock Value CommonStockValue	207000	USD
CY2011Q1	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	USD
CY2012Q1	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	USD
	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	-449000	USD
CY2012Q1	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	65000	USD
CY2011Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	913000	USD
CY2012Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1454000	USD
CY2011Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3136000	USD
CY2011Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	174000	USD
CY2012Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	175000	USD
CY2011Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	-81476000	USD
CY2012Q1	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	-86318000	USD
CY2011Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.07
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2012Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43447000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10664000	USD
CY2012Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2011Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2012Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	20000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	542000	USD
CY2011Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-269000	USD
CY2012Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	20000	USD
CY2011Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1458000	USD
CY2011Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1316000	USD
CY2012Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2011Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	449000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31293000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1042000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-602000	USD
CY2011Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-137000	USD
CY2012Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2000	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2000	USD
CY2011Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-8000	USD
CY2012Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-35000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2746000	USD
CY2011Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-418000	USD
	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	350000	USD
CY2012Q1	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	0	USD
CY2011Q1	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	0	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	918000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	722000	USD
CY2011Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-65000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	292000	USD
CY2012Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-117000	USD
CY2011Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	418000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	151000	USD
CY2012Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	8000	USD
CY2011Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	11000	USD
CY2012Q1	us-gaap	Interest Paid InterestPaid	10000	USD
	us-gaap	Interest Paid InterestPaid	114000	USD
CY2011Q1	us-gaap	Interest Paid InterestPaid	11000	USD
CY2012Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	2000	USD
CY2011Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	1000	USD
CY2011Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1757000	USD
CY2012Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000	USD
CY2012Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	4873000	USD
CY2011Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	4459000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	11606000	USD
CY2012Q1	us-gaap	Liabilities Liabilities	10649000	USD
CY2011Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	942000	USD
CY2012Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2310000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48379000	USD
CY2012Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8339000	USD
CY2011Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	93000	USD
CY2012Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	93000	USD
CY2011Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3333000	USD
CY2012Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3629000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-41000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	119062000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	78000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	221000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-659000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10388000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5640000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4336000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-75405000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-86278000	USD
CY2011Q1	us-gaap	Net Income Loss NetIncomeLoss	-3897000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-4842000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-583000	USD
CY2011Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000	USD
CY2012Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2012Q1	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2011Q4	us-gaap	Notes Payable Current NotesPayableCurrent	6000000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	5288000	USD
	us-gaap	Operating Expenses OperatingExpenses	95441000	USD
CY2011Q1	us-gaap	Operating Expenses OperatingExpenses	4496000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-89253000	USD
CY2011Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3892000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4817000	USD
CY2011Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	337000	USD
CY2012Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	-21000	USD
CY2012Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4000	USD
CY2012Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2012Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-25000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2392000	USD
CY2011Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6000	USD
CY2011Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	505000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	120000	USD
CY2011Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	11290000	USD
CY2011Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2012Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	709000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7478000	USD
CY2011Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48000	USD
CY2011Q1	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	0	USD
CY2012Q1	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	0	USD
	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	113000	USD
CY2011Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	409000	USD
CY2012Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	292000	USD
CY2011Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	135000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	41295000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	67743000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2011Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	3479000	USD
CY2011Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2012Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2012Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2011Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	7759000	USD
CY2012Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	50000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	50000	USD
CY2011Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Profit Loss ProfitLoss	-86861000	USD
CY2012Q1	us-gaap	Profit Loss ProfitLoss	-4842000	USD
CY2011Q1	us-gaap	Profit Loss ProfitLoss	-3898000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8502000	USD
CY2012Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9246000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5591000	USD
CY2012Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6229000	USD
CY2012Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	744000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	710000	USD
CY2011Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	31000	USD
CY2012Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	30000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	392000	USD
CY2012Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	23000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	317000	USD
CY2011Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	23000	USD
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3830000	USD
CY2011Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3180000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	64148000	USD
CY2011Q1	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	1629000	USD
CY2012Q1	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2011Q1	us-gaap	Revenue From Grants RevenueFromGrants	604000	USD
CY2012Q1	us-gaap	Revenue From Grants RevenueFromGrants	471000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	6188000	USD
CY2011Q1	us-gaap	Share Based Compensation ShareBasedCompensation	368000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	736000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6085000	USD
CY2011Q1	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2012Q1	us-gaap	Stock Issued1 StockIssued1	0	USD
	us-gaap	Stock Issued1 StockIssued1	1654000	USD
CY2012Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	736000	USD
CY2012Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	135000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	36773000	USD
CY2012Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32798000	USD
CY2012Q1	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	0	USD
CY2011Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	0	USD
CY2012Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.01
CY2012Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	0	shares
CY2011Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	0	shares
CY2011Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2012Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2011Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2012Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2012Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	-4000	USD
CY2011Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3636044	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20613146	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic		shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20613146	shares
CY2011Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3636044	shares
CY2012Q1	nlnk	Cash And Cash Equivalents Excluding Certificates Of Deposit CashAndCashEquivalentsExcludingCertificatesOfDeposit	33269000	USD
CY2011Q4	nlnk	Cash And Cash Equivalents Excluding Certificates Of Deposit CashAndCashEquivalentsExcludingCertificatesOfDeposit	39490000	USD
	nlnk	Forgiveness Of Notes Receivable From Related Parties ForgivenessOfNotesReceivableFromRelatedParties	350000	USD
CY2012Q1	nlnk	Forgiveness Of Notes Receivable From Related Parties ForgivenessOfNotesReceivableFromRelatedParties	0	USD
CY2011Q1	nlnk	Forgiveness Of Notes Receivable From Related Parties ForgivenessOfNotesReceivableFromRelatedParties	0	USD
	nlnk	Increase Decrease In State Research And Development Credit Receivable IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable	247000	USD
CY2011Q1	nlnk	Increase Decrease In State Research And Development Credit Receivable IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable	80000	USD
CY2012Q1	nlnk	Increase Decrease In State Research And Development Credit Receivable IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable	45000	USD
CY2012Q1	nlnk	Noncash Issuance Of Common Stock Dividend To Preferred Shareholders NoncashIssuanceOfCommonStockDividendToPreferredShareholders	0	USD
	nlnk	Noncash Issuance Of Common Stock Dividend To Preferred Shareholders NoncashIssuanceOfCommonStockDividendToPreferredShareholders	6000	USD
CY2012Q1	nlnk	State Research And Development Credit Receivable StateResearchAndDevelopmentCreditReceivable	247000	USD
CY2012Q1	dei	Amendment Flag AmendmentFlag	false
CY2012Q1	dei	Document Period End Date DocumentPeriodEndDate	2012-03-31
CY2011Q1	nlnk	Noncash Issuance Of Common Stock Dividend To Preferred Shareholders NoncashIssuanceOfCommonStockDividendToPreferredShareholders	0	USD
	nlnk	Repayments Advances Of Notes Receivable For Common Stock RepaymentsAdvancesOfNotesReceivableForCommonStock	0	USD
CY2012Q1	nlnk	Repayments Advances Of Notes Receivable For Common Stock RepaymentsAdvancesOfNotesReceivableForCommonStock	0	USD
CY2011Q1	nlnk	Repayments Advances Of Notes Receivable For Common Stock RepaymentsAdvancesOfNotesReceivableForCommonStock	-13000	USD
CY2011Q4	nlnk	State Research And Development Credit Receivable StateResearchAndDevelopmentCreditReceivable	202000	USD
CY2012Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2012Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2012Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012Q1	dei	Document Type DocumentType	10-Q
CY2012Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001126234
CY2012Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20672029	shares
CY2012Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2012Q1	dei	Entity Registrant Name EntityRegistrantName	NEWLINK GENETICS CORP

Files In Submission

Name	View Source	Status
0001126234-12-000024-index-headers.html	Edgar Link	pending
0001126234-12-000024-index.html	Edgar Link	pending
0001126234-12-000024.txt	Edgar Link	pending
0001126234-12-000024-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
nlnk-20120331.xml	Edgar Link	completed
nlnk-20120331.xsd	Edgar Link	pending
nlnk-20120331x10q.htm	Edgar Link	pending
nlnk-20120331xex106.htm	Edgar Link	pending
nlnk-20120331xex311.htm	Edgar Link	pending
nlnk-20120331xex312.htm	Edgar Link	pending
nlnk-20120331xex321.htm	Edgar Link	pending
nlnk-20120331xex43.htm	Edgar Link	pending
nlnk-20120331_cal.xml	Edgar Link	unprocessable
nlnk-20120331_def.xml	Edgar Link	unprocessable
nlnk-20120331_lab.xml	Edgar Link	unprocessable
nlnk-20120331_pre.xml	Edgar Link	unprocessable
nlnk20120331ex1061.gif	Edgar Link	pending
nlnk20120331ex1062.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LUMO
Lumos Pharma Inc Stock $lumo

2012 Q1 Form 10-Q Financial Statement

#000112623412000024 Filed on May 10, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUMO Lumos Pharma Inc Stock $lumo

2012 Q1 Form 10-Q Financial Statement

#000112623412000024 Filed on May 10, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUMO
Lumos Pharma Inc Stock $lumo